Gary Borzillo
Director, Clinical Sciences Oncology, Translational Research Johnson & Johnson
Seminars
Wednesday 5th November 2025
Summary Panel Discussion: Evaluating the Key Opportunities & Challenges to Improve ADC Translational Performance & Strategy
2:30 pm
Bring your burning questions to this closing panel session with the Translational Medicine speakers. Hear the speakers delve into themes across clinical pharmacology and ADC dose escalation, biomarker technologies to select the right patients for the right ADC, and
strategies to set up your phase I ADC development for success
Wednesday 5th November 2025
Chair:
Download the Full Event Guide for full details
